Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
Saved in:
Main Authors: | Hong-fen Guo, Nai-Kong V Cheung, Jeong A Park, Alan Long, Tsung-Yi Lin |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1417a766f63b4510809ccc4f8117efda |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies
by: Christina L. Parker, et al.
Published: (2020) -
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning
by: Lauric Haber, et al.
Published: (2021) -
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
by: Barbara Savoldo, et al.
Published: (2021) -
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity
by: Congcong Zhang, et al.
Published: (2021) -
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
by: Xiaopei Cui, et al.
Published: (2021)